As of April 16, 2025, Atea Pharmaceuticals (AVIR) has a market cap of $0.24 billion USD. According to our data, Atea Pharmaceuticals is ranked No.6783 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.24 B |
-14.76%
|
Dec 31, 2024 | $0.28 B |
9.84%
|
Dec 29, 2023 | $0.26 B |
-36.59%
|
Dec 30, 2022 | $0.41 B |
-46.20%
|
Dec 31, 2021 | $0.76 B |
-78.60%
|
Dec 31, 2020 | $3.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
Market Cap | = | AVIR Stock Price | * | AVIR Shares Outstanding |
= | $2.82 | * | 85.53 M | |
= | $0.24 B |